Structure–Activity Relationship Studies of α‑Ketoamides as Inhibitors of the Phospholipase A and Acyltransferase Enzyme Family

The phospholipase A and acyltransferase (PLAAT) family of cysteine hydrolases consists of five members, which are involved in the Ca2+-independent production of N-acylphosphatidylethanolamines (NAPEs). NAPEs are lipid precursors for bioactive N-acylethanolamines (NAEs) that are involved in various p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2020-09, Vol.63 (17), p.9340-9359
Hauptverfasser: Zhou, Juan, Mock, Elliot D, Al Ayed, Karol, Di, Xinyu, Kantae, Vasudev, Burggraaff, Lindsey, Stevens, Anna F, Martella, Andrea, Mohr, Florian, Jiang, Ming, van der Wel, Tom, Wendel, Tiemen J, Ofman, Tim P, Tran, Yvonne, de Koster, Nicky, van Westen, Gerard J.P, Hankemeier, Thomas, van der Stelt, Mario
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 9359
container_issue 17
container_start_page 9340
container_title Journal of medicinal chemistry
container_volume 63
creator Zhou, Juan
Mock, Elliot D
Al Ayed, Karol
Di, Xinyu
Kantae, Vasudev
Burggraaff, Lindsey
Stevens, Anna F
Martella, Andrea
Mohr, Florian
Jiang, Ming
van der Wel, Tom
Wendel, Tiemen J
Ofman, Tim P
Tran, Yvonne
de Koster, Nicky
van Westen, Gerard J.P
Hankemeier, Thomas
van der Stelt, Mario
description The phospholipase A and acyltransferase (PLAAT) family of cysteine hydrolases consists of five members, which are involved in the Ca2+-independent production of N-acylphosphatidylethanolamines (NAPEs). NAPEs are lipid precursors for bioactive N-acylethanolamines (NAEs) that are involved in various physiological processes such as food intake, pain, inflammation, stress, and anxiety. Recently, we identified α-ketoamides as the first pan-active PLAAT inhibitor scaffold that reduced arachidonic acid levels in PLAAT3-overexpressing U2OS cells and in HepG2 cells. Here, we report the structure–activity relationships of the α-ketoamide series using activity-based protein profiling. This led to the identification of LEI-301, a nanomolar potent inhibitor for the PLAAT family members. LEI-301 reduced the NAE levels, including anandamide, in cells overexpressing PLAAT2 or PLAAT5. Collectively, LEI-301 may help to dissect the physiological role of the PLAATs.
doi_str_mv 10.1021/acs.jmedchem.0c00522
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7498158</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2434059523</sourcerecordid><originalsourceid>FETCH-LOGICAL-a449t-db860b29f034ba1c5a860ccef7e68043f7bd97c791640ec21ae2bc5d0775de2f3</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxi1ERZfCGyDkI5cs4z_ZJBekVdVCRaUiCmfLcSbEVRIvtlMpnCrxBIgn4UV4iD4J3u62ggsny-Pv-814PkJeMFgy4Oy1NmF5NWBjOhyWYAByzh-RBcs5ZLIE-ZgsADjP-IqLQ_I0hCsAEIyLJ-RQ8KIsmCgX5Ptl9JOJk8fbm59rE-21jTP9iL2O1o2hsxt6GafGYqCupb9_3d78eI_R6cE2qaQDPRs7W9vo_J0gdkg_dC5sOtfbjQ5I11SPDV2buY9ej6FFv62ejN_mAelp4vTzM3LQ6j7g8_15RD6fnnw6fpedX7w9O16fZ1rKKmZNXa6g5lULQtaamVynuzHYFrhK_xVtUTdVYYqKrSSg4Uwjr03eQFHkDfJWHJE3O-5mqreLwzGN1KuNt4P2s3Laqn9fRtupL-5aFbIqWV4mwKs9wLuvE4aoBhsM9r0e0U1BcSkk5FXORZLKndR4F4LH9qENA7XNT6X81H1-ap9fsr38e8QH031gSQA7wZ3dTX5MG_s_8w8ML7Fl</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2434059523</pqid></control><display><type>article</type><title>Structure–Activity Relationship Studies of α‑Ketoamides as Inhibitors of the Phospholipase A and Acyltransferase Enzyme Family</title><source>ACS Publications</source><source>MEDLINE</source><creator>Zhou, Juan ; Mock, Elliot D ; Al Ayed, Karol ; Di, Xinyu ; Kantae, Vasudev ; Burggraaff, Lindsey ; Stevens, Anna F ; Martella, Andrea ; Mohr, Florian ; Jiang, Ming ; van der Wel, Tom ; Wendel, Tiemen J ; Ofman, Tim P ; Tran, Yvonne ; de Koster, Nicky ; van Westen, Gerard J.P ; Hankemeier, Thomas ; van der Stelt, Mario</creator><creatorcontrib>Zhou, Juan ; Mock, Elliot D ; Al Ayed, Karol ; Di, Xinyu ; Kantae, Vasudev ; Burggraaff, Lindsey ; Stevens, Anna F ; Martella, Andrea ; Mohr, Florian ; Jiang, Ming ; van der Wel, Tom ; Wendel, Tiemen J ; Ofman, Tim P ; Tran, Yvonne ; de Koster, Nicky ; van Westen, Gerard J.P ; Hankemeier, Thomas ; van der Stelt, Mario</creatorcontrib><description>The phospholipase A and acyltransferase (PLAAT) family of cysteine hydrolases consists of five members, which are involved in the Ca2+-independent production of N-acylphosphatidylethanolamines (NAPEs). NAPEs are lipid precursors for bioactive N-acylethanolamines (NAEs) that are involved in various physiological processes such as food intake, pain, inflammation, stress, and anxiety. Recently, we identified α-ketoamides as the first pan-active PLAAT inhibitor scaffold that reduced arachidonic acid levels in PLAAT3-overexpressing U2OS cells and in HepG2 cells. Here, we report the structure–activity relationships of the α-ketoamide series using activity-based protein profiling. This led to the identification of LEI-301, a nanomolar potent inhibitor for the PLAAT family members. LEI-301 reduced the NAE levels, including anandamide, in cells overexpressing PLAAT2 or PLAAT5. Collectively, LEI-301 may help to dissect the physiological role of the PLAATs.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.0c00522</identifier><identifier>PMID: 32787138</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Acyltransferases - antagonists &amp; inhibitors ; Acyltransferases - chemistry ; Amides - chemistry ; Amides - pharmacology ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - pharmacology ; Hep G2 Cells ; Humans ; Models, Molecular ; Phospholipases - antagonists &amp; inhibitors ; Phospholipases - chemistry ; Protein Conformation ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 2020-09, Vol.63 (17), p.9340-9359</ispartof><rights>Copyright © 2020 American Chemical Society 2020 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a449t-db860b29f034ba1c5a860ccef7e68043f7bd97c791640ec21ae2bc5d0775de2f3</citedby><cites>FETCH-LOGICAL-a449t-db860b29f034ba1c5a860ccef7e68043f7bd97c791640ec21ae2bc5d0775de2f3</cites><orcidid>0000-0003-0717-1817 ; 0000-0002-2442-0443 ; 0000-0002-1500-2856 ; 0000-0002-1181-7134 ; 0000-0001-7871-2073 ; 0000-0002-1029-5717</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00522$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00522$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,776,780,881,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32787138$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhou, Juan</creatorcontrib><creatorcontrib>Mock, Elliot D</creatorcontrib><creatorcontrib>Al Ayed, Karol</creatorcontrib><creatorcontrib>Di, Xinyu</creatorcontrib><creatorcontrib>Kantae, Vasudev</creatorcontrib><creatorcontrib>Burggraaff, Lindsey</creatorcontrib><creatorcontrib>Stevens, Anna F</creatorcontrib><creatorcontrib>Martella, Andrea</creatorcontrib><creatorcontrib>Mohr, Florian</creatorcontrib><creatorcontrib>Jiang, Ming</creatorcontrib><creatorcontrib>van der Wel, Tom</creatorcontrib><creatorcontrib>Wendel, Tiemen J</creatorcontrib><creatorcontrib>Ofman, Tim P</creatorcontrib><creatorcontrib>Tran, Yvonne</creatorcontrib><creatorcontrib>de Koster, Nicky</creatorcontrib><creatorcontrib>van Westen, Gerard J.P</creatorcontrib><creatorcontrib>Hankemeier, Thomas</creatorcontrib><creatorcontrib>van der Stelt, Mario</creatorcontrib><title>Structure–Activity Relationship Studies of α‑Ketoamides as Inhibitors of the Phospholipase A and Acyltransferase Enzyme Family</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>The phospholipase A and acyltransferase (PLAAT) family of cysteine hydrolases consists of five members, which are involved in the Ca2+-independent production of N-acylphosphatidylethanolamines (NAPEs). NAPEs are lipid precursors for bioactive N-acylethanolamines (NAEs) that are involved in various physiological processes such as food intake, pain, inflammation, stress, and anxiety. Recently, we identified α-ketoamides as the first pan-active PLAAT inhibitor scaffold that reduced arachidonic acid levels in PLAAT3-overexpressing U2OS cells and in HepG2 cells. Here, we report the structure–activity relationships of the α-ketoamide series using activity-based protein profiling. This led to the identification of LEI-301, a nanomolar potent inhibitor for the PLAAT family members. LEI-301 reduced the NAE levels, including anandamide, in cells overexpressing PLAAT2 or PLAAT5. Collectively, LEI-301 may help to dissect the physiological role of the PLAATs.</description><subject>Acyltransferases - antagonists &amp; inhibitors</subject><subject>Acyltransferases - chemistry</subject><subject>Amides - chemistry</subject><subject>Amides - pharmacology</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Hep G2 Cells</subject><subject>Humans</subject><subject>Models, Molecular</subject><subject>Phospholipases - antagonists &amp; inhibitors</subject><subject>Phospholipases - chemistry</subject><subject>Protein Conformation</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc9u1DAQxi1ERZfCGyDkI5cs4z_ZJBekVdVCRaUiCmfLcSbEVRIvtlMpnCrxBIgn4UV4iD4J3u62ggsny-Pv-814PkJeMFgy4Oy1NmF5NWBjOhyWYAByzh-RBcs5ZLIE-ZgsADjP-IqLQ_I0hCsAEIyLJ-RQ8KIsmCgX5Ptl9JOJk8fbm59rE-21jTP9iL2O1o2hsxt6GafGYqCupb9_3d78eI_R6cE2qaQDPRs7W9vo_J0gdkg_dC5sOtfbjQ5I11SPDV2buY9ej6FFv62ejN_mAelp4vTzM3LQ6j7g8_15RD6fnnw6fpedX7w9O16fZ1rKKmZNXa6g5lULQtaamVynuzHYFrhK_xVtUTdVYYqKrSSg4Uwjr03eQFHkDfJWHJE3O-5mqreLwzGN1KuNt4P2s3Laqn9fRtupL-5aFbIqWV4mwKs9wLuvE4aoBhsM9r0e0U1BcSkk5FXORZLKndR4F4LH9qENA7XNT6X81H1-ap9fsr38e8QH031gSQA7wZ3dTX5MG_s_8w8ML7Fl</recordid><startdate>20200910</startdate><enddate>20200910</enddate><creator>Zhou, Juan</creator><creator>Mock, Elliot D</creator><creator>Al Ayed, Karol</creator><creator>Di, Xinyu</creator><creator>Kantae, Vasudev</creator><creator>Burggraaff, Lindsey</creator><creator>Stevens, Anna F</creator><creator>Martella, Andrea</creator><creator>Mohr, Florian</creator><creator>Jiang, Ming</creator><creator>van der Wel, Tom</creator><creator>Wendel, Tiemen J</creator><creator>Ofman, Tim P</creator><creator>Tran, Yvonne</creator><creator>de Koster, Nicky</creator><creator>van Westen, Gerard J.P</creator><creator>Hankemeier, Thomas</creator><creator>van der Stelt, Mario</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0717-1817</orcidid><orcidid>https://orcid.org/0000-0002-2442-0443</orcidid><orcidid>https://orcid.org/0000-0002-1500-2856</orcidid><orcidid>https://orcid.org/0000-0002-1181-7134</orcidid><orcidid>https://orcid.org/0000-0001-7871-2073</orcidid><orcidid>https://orcid.org/0000-0002-1029-5717</orcidid></search><sort><creationdate>20200910</creationdate><title>Structure–Activity Relationship Studies of α‑Ketoamides as Inhibitors of the Phospholipase A and Acyltransferase Enzyme Family</title><author>Zhou, Juan ; Mock, Elliot D ; Al Ayed, Karol ; Di, Xinyu ; Kantae, Vasudev ; Burggraaff, Lindsey ; Stevens, Anna F ; Martella, Andrea ; Mohr, Florian ; Jiang, Ming ; van der Wel, Tom ; Wendel, Tiemen J ; Ofman, Tim P ; Tran, Yvonne ; de Koster, Nicky ; van Westen, Gerard J.P ; Hankemeier, Thomas ; van der Stelt, Mario</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a449t-db860b29f034ba1c5a860ccef7e68043f7bd97c791640ec21ae2bc5d0775de2f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acyltransferases - antagonists &amp; inhibitors</topic><topic>Acyltransferases - chemistry</topic><topic>Amides - chemistry</topic><topic>Amides - pharmacology</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Hep G2 Cells</topic><topic>Humans</topic><topic>Models, Molecular</topic><topic>Phospholipases - antagonists &amp; inhibitors</topic><topic>Phospholipases - chemistry</topic><topic>Protein Conformation</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhou, Juan</creatorcontrib><creatorcontrib>Mock, Elliot D</creatorcontrib><creatorcontrib>Al Ayed, Karol</creatorcontrib><creatorcontrib>Di, Xinyu</creatorcontrib><creatorcontrib>Kantae, Vasudev</creatorcontrib><creatorcontrib>Burggraaff, Lindsey</creatorcontrib><creatorcontrib>Stevens, Anna F</creatorcontrib><creatorcontrib>Martella, Andrea</creatorcontrib><creatorcontrib>Mohr, Florian</creatorcontrib><creatorcontrib>Jiang, Ming</creatorcontrib><creatorcontrib>van der Wel, Tom</creatorcontrib><creatorcontrib>Wendel, Tiemen J</creatorcontrib><creatorcontrib>Ofman, Tim P</creatorcontrib><creatorcontrib>Tran, Yvonne</creatorcontrib><creatorcontrib>de Koster, Nicky</creatorcontrib><creatorcontrib>van Westen, Gerard J.P</creatorcontrib><creatorcontrib>Hankemeier, Thomas</creatorcontrib><creatorcontrib>van der Stelt, Mario</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhou, Juan</au><au>Mock, Elliot D</au><au>Al Ayed, Karol</au><au>Di, Xinyu</au><au>Kantae, Vasudev</au><au>Burggraaff, Lindsey</au><au>Stevens, Anna F</au><au>Martella, Andrea</au><au>Mohr, Florian</au><au>Jiang, Ming</au><au>van der Wel, Tom</au><au>Wendel, Tiemen J</au><au>Ofman, Tim P</au><au>Tran, Yvonne</au><au>de Koster, Nicky</au><au>van Westen, Gerard J.P</au><au>Hankemeier, Thomas</au><au>van der Stelt, Mario</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structure–Activity Relationship Studies of α‑Ketoamides as Inhibitors of the Phospholipase A and Acyltransferase Enzyme Family</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2020-09-10</date><risdate>2020</risdate><volume>63</volume><issue>17</issue><spage>9340</spage><epage>9359</epage><pages>9340-9359</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>The phospholipase A and acyltransferase (PLAAT) family of cysteine hydrolases consists of five members, which are involved in the Ca2+-independent production of N-acylphosphatidylethanolamines (NAPEs). NAPEs are lipid precursors for bioactive N-acylethanolamines (NAEs) that are involved in various physiological processes such as food intake, pain, inflammation, stress, and anxiety. Recently, we identified α-ketoamides as the first pan-active PLAAT inhibitor scaffold that reduced arachidonic acid levels in PLAAT3-overexpressing U2OS cells and in HepG2 cells. Here, we report the structure–activity relationships of the α-ketoamide series using activity-based protein profiling. This led to the identification of LEI-301, a nanomolar potent inhibitor for the PLAAT family members. LEI-301 reduced the NAE levels, including anandamide, in cells overexpressing PLAAT2 or PLAAT5. Collectively, LEI-301 may help to dissect the physiological role of the PLAATs.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>32787138</pmid><doi>10.1021/acs.jmedchem.0c00522</doi><tpages>20</tpages><orcidid>https://orcid.org/0000-0003-0717-1817</orcidid><orcidid>https://orcid.org/0000-0002-2442-0443</orcidid><orcidid>https://orcid.org/0000-0002-1500-2856</orcidid><orcidid>https://orcid.org/0000-0002-1181-7134</orcidid><orcidid>https://orcid.org/0000-0001-7871-2073</orcidid><orcidid>https://orcid.org/0000-0002-1029-5717</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2020-09, Vol.63 (17), p.9340-9359
issn 0022-2623
1520-4804
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7498158
source ACS Publications; MEDLINE
subjects Acyltransferases - antagonists & inhibitors
Acyltransferases - chemistry
Amides - chemistry
Amides - pharmacology
Enzyme Inhibitors - chemistry
Enzyme Inhibitors - pharmacology
Hep G2 Cells
Humans
Models, Molecular
Phospholipases - antagonists & inhibitors
Phospholipases - chemistry
Protein Conformation
Structure-Activity Relationship
title Structure–Activity Relationship Studies of α‑Ketoamides as Inhibitors of the Phospholipase A and Acyltransferase Enzyme Family
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T20%3A19%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structure%E2%80%93Activity%20Relationship%20Studies%20of%20%CE%B1%E2%80%91Ketoamides%20as%20Inhibitors%20of%20the%20Phospholipase%20A%20and%20Acyltransferase%20Enzyme%20Family&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Zhou,%20Juan&rft.date=2020-09-10&rft.volume=63&rft.issue=17&rft.spage=9340&rft.epage=9359&rft.pages=9340-9359&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.0c00522&rft_dat=%3Cproquest_pubme%3E2434059523%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2434059523&rft_id=info:pmid/32787138&rfr_iscdi=true